济川药业：全资子公司取得药品注册证书

Core Viewpoint - Jichuan Pharmaceutical has received approval for its Lidocaine Gel Patch from the National Medical Products Administration, which may enhance its product portfolio and revenue potential [1] Company Summary - Jichuan Pharmaceutical's subsidiary, Shaanxi Dongke Pharmaceutical Co., Ltd., has been granted a drug registration certificate for Lidocaine Gel Patch [1] - As of the latest report, Jichuan Pharmaceutical's market capitalization stands at 23.5 billion yuan [1] Revenue Composition - For the year 2024, Jichuan Pharmaceutical's revenue composition is as follows: - Heat-clearing and detoxifying products: 33.53% - Pediatric products: 28.11% - Digestive products: 14.41% - Other sectors: 9.94% - Respiratory products: 8.13% [1]